Agilent Technologies Future Growth
Future criteria checks 2/6
Agilent Technologies is forecast to grow earnings and revenue by 9% and 5.2% per annum respectively. EPS is expected to grow by 9.8% per annum. Return on equity is forecast to be 25.8% in 3 years.
Key information
9.0%
Earnings growth rate
9.8%
EPS growth rate
Life Sciences earnings growth | 17.4% |
Revenue growth rate | 5.2% |
Future return on equity | 25.8% |
Analyst coverage | Good |
Last updated | 24 Apr 2024 |
Recent future growth updates
Recent updates
These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Reasonably Well
Apr 05Agilent Technologies: Cash Flow Returns On Investments And Conventional All Point To A Hold
Mar 12Agilent Technologies Hit A Homerun
Dec 24Agilent: A Wide Moat Company Expected To Return To Growth In 2024 (Rating Upgrade)
Dec 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Dec 07Agilent Technologies: Looking Undervalued Heading Into Earnings
Nov 17Estimating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Oct 26Agilent: Dips Into GARP Territory, Shares At A Crucial Spot On The Chart
Sep 26Is It Too Late To Consider Buying Agilent Technologies, Inc. (NYSE:A)?
Sep 08Agilent Technologies (NYSE:A) Seems To Use Debt Quite Sensibly
Aug 21Calculating The Fair Value Of Agilent Technologies, Inc. (NYSE:A)
Jul 23Agilent Technologies - A Wealth Compounder 30% Below Its Highs
Jul 13Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Jul 10What Is Agilent Technologies, Inc.'s (NYSE:A) Share Price Doing?
May 28Agilent Technologies Stock: Starting To Look Appealing
May 25These 4 Measures Indicate That Agilent Technologies (NYSE:A) Is Using Debt Safely
Apr 17Calculating The Intrinsic Value Of Agilent Technologies, Inc. (NYSE:A)
Apr 03Here's Why We Think Agilent Technologies (NYSE:A) Might Deserve Your Attention Today
Mar 21Agilent Technologies, Inc.'s (NYSE:A) CEO Compensation Is Looking A Bit Stretched At The Moment
Mar 09Agilent Technologies declares $0.225 dividend
Feb 22Fluor's unit gets contract to expand Agilent's manufacturing facility in Colorado
Feb 16Is There Now An Opportunity In Agilent Technologies, Inc. (NYSE:A)?
Jan 30Agilent Technologies: A Proven Track Record Of Shareholder Value Creation, Hold
Jan 16Agilent to acquire Avida for cancer research
Jan 04Agilent Technologies (NYSE:A) Has A Rock Solid Balance Sheet
Dec 30Agilent's liquid biopsy test gets FDA nod for companion diagnostic test to Mirati's Krazati
Dec 13Agilent Technologies raises quarterly dividend by 7.1% to $0.225/share
Nov 16Is Agilent Technologies, Inc. (NYSE:A) Worth US$138 Based On Its Intrinsic Value?
Nov 08Why Agilent Technologies, Inc. (NYSE:A) Could Be Worth Watching
Oct 26Here's Why Agilent Technologies (NYSE:A) Has Caught The Eye Of Investors
Oct 02Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
10/31/2026 | 7,664 | 1,649 | 1,756 | 2,092 | 13 |
10/31/2025 | 7,232 | 1,504 | 1,574 | 1,903 | 18 |
10/31/2024 | 6,776 | 1,340 | 1,351 | 1,728 | 18 |
1/31/2024 | 6,735 | 1,236 | 1,649 | 1,961 | N/A |
10/31/2023 | 6,833 | 1,240 | 1,474 | 1,772 | N/A |
7/31/2023 | 6,994 | 1,133 | 1,420 | 1,704 | N/A |
4/30/2023 | 7,040 | 1,351 | 1,183 | 1,468 | N/A |
1/31/2023 | 6,930 | 1,323 | 1,061 | 1,353 | N/A |
10/31/2022 | 6,848 | 1,254 | 1,021 | 1,312 | N/A |
7/31/2022 | 6,659 | 1,328 | 1,022 | 1,305 | N/A |
4/30/2022 | 6,527 | 1,263 | 1,058 | 1,313 | N/A |
1/31/2022 | 6,445 | 1,205 | 1,280 | 1,502 | N/A |
10/31/2021 | 6,319 | 1,210 | 1,297 | 1,485 | N/A |
7/31/2021 | 6,142 | 990 | 1,268 | 1,421 | N/A |
4/30/2021 | 5,817 | 925 | 1,253 | 1,377 | N/A |
1/31/2021 | 5,530 | 810 | 1,092 | 1,218 | N/A |
10/31/2020 | 5,339 | 719 | 802 | 921 | N/A |
7/31/2020 | 5,223 | 691 | 736 | 858 | N/A |
4/30/2020 | 5,236 | 683 | 665 | 810 | N/A |
1/31/2020 | 5,236 | 764 | 598 | 749 | N/A |
10/31/2019 | 5,163 | 1,071 | 865 | 1,021 | N/A |
7/31/2019 | 5,090 | 1,072 | 917 | 1,079 | N/A |
4/30/2019 | 5,019 | 1,117 | 887 | 1,034 | N/A |
1/31/2019 | 4,987 | 1,140 | 929 | 1,085 | N/A |
10/31/2018 | 4,914 | 316 | 910 | 1,087 | N/A |
7/31/2018 | 4,809 | 298 | 804 | 1,003 | N/A |
4/30/2018 | 4,720 | 237 | 825 | 1,034 | N/A |
1/31/2018 | 4,616 | 196 | 784 | 988 | N/A |
10/31/2017 | 4,472 | 684 | N/A | 889 | N/A |
7/31/2017 | 4,394 | 633 | N/A | 835 | N/A |
4/30/2017 | 4,324 | 582 | N/A | 801 | N/A |
1/31/2017 | 4,241 | 509 | N/A | 798 | N/A |
10/31/2016 | 4,202 | 462 | N/A | 793 | N/A |
7/31/2016 | 4,126 | 476 | N/A | 800 | N/A |
4/30/2016 | 4,096 | 465 | N/A | 714 | N/A |
1/31/2016 | 4,040 | 466 | N/A | 643 | N/A |
10/31/2015 | 4,038 | 438 | N/A | 1,322 | N/A |
7/31/2015 | 4,046 | 306 | N/A | 1,245 | N/A |
4/30/2015 | 4,041 | 256 | N/A | 1,165 | N/A |
1/31/2015 | 4,066 | 204 | N/A | 1,307 | N/A |
10/31/2014 | 4,048 | 232 | N/A | 731 | N/A |
7/31/2014 | 4,723 | 435 | N/A | 924 | N/A |
4/30/2014 | 5,366 | 540 | N/A | 1,111 | N/A |
1/31/2014 | 6,110 | 666 | N/A | 1,101 | N/A |
10/31/2013 | 3,894 | 225 | N/A | 1,152 | N/A |
7/31/2013 | 6,831 | 938 | N/A | 1,260 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A's forecast earnings growth (9% per year) is above the savings rate (2.4%).
Earnings vs Market: A's earnings (9% per year) are forecast to grow slower than the US market (14.1% per year).
High Growth Earnings: A's earnings are forecast to grow, but not significantly.
Revenue vs Market: A's revenue (5.2% per year) is forecast to grow slower than the US market (8.2% per year).
High Growth Revenue: A's revenue (5.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A's Return on Equity is forecast to be high in 3 years time (25.8%)